*|MC:SUBJECT|*
Email Sent by the Excellence in Pediatrics Institute
Join live and hear from Paul Gissen, on May 11, 2022, at 13:00 CEST for a 30-minute case studies presentation looking at: Emerging Knowledge - The Early Indications of MLD in Children. The presentation will be followed by 15 minutes of questions from the audience.

Dear colleague,

We are pleased to invite you to the next Excellence in Pediatrics Webinar in our Spring Program, all part of our ongoing campaign to help pediatricians ’Think Rare'. Join us for the third webinar of Series 2 of the Spot the Early Signs of Metachromatic Leukodystrophy (MLD) Webinar Series on May 4, 2022.  Attendance is free and you can register for one or more webinars here.

Can't attend a live webinar? By registering, you will receive a link to the on-demand version after the session concludes.

Don't forget to mark your calendar!

Yours sincerely,

Excellence in Pediatrics Institute

FREE REGISTRATION HERE
HELP US  INCREASE AWARENESS OF METACHROMATIC LEUKODYSTROPHY (MLD) 

Please share the prepared message below to your network through your Twitter and/or Facebook account and send a message to a colleague. Help us to help everyone to ‘Think Rare’ and look for MLD in every consultation. Click on the icons below to share the message

Click to Tweet Click to Tweet
Facebook Share Facebook Share
Send Email to colleague Send Email to colleague

THE SPOT THE EARLY SIGNS OF MLD COURSE PROGRAM

Metachromatic Leukodystrophy (MLD) is a rare hereditary disease characterized by the accumulation of fats called sulfatides. This causes the destruction of the protective fatty layer (myelin sheath) surrounding the nerves in both the central nervous system and the peripheral nervous system, ultimately affecting intellectual and motor function. Early-onset clinical manifestations are often overlooked or confused with other conditions causing confusion among non-trained HCPs at first contact, resulting in misdiagnosis, wrong referral routes and delays in the early start of treatment. Delays in starting treatment have significant consequences on the conditions’ development, and the patient’s health and quality of life. This delay in referral and treatment must be overcome. 

LEARNING OBJECTIVES

✓ Recapping the main early signs and symptoms of MLD in children     

✓ Examining the latest emerging studies on new signs of MLD and what to look for    

✓ Understanding the limitations of private tests that only look for a certain number of common mutations - Does a negative genetic text always rules out MLD?    

✓ Exploring when to refer patients and eliminating the misdiagnoses of MLD with other conditions    

✓ Case Study example of Gallbladder abnormalities in children with MLD that occur at a far greater incidence than other LSDs

TARGET AUDIENCE

This educational activity is designed for an international audience of General Pediatricians, General Practitioners, Pediatric Neurologists and other physicians and healthcare professionals with an interest in Metabolic Diseases and Genetics.

Missed the previously organised webinars
in the series?
WATCH THE VIDEOS OF THE WEBINARS NOW
FREE REGISTRATION FOR ALL LIVE & RECORDED WEBINARS IN THE SERIES
EXPLORE EIP's METACHROMATIC LEUKODYSTROPHY (MLD) RESOURCE CENTER TO ACCESS FREE THE TRAININGS & CME COURSE FROM SERIES 1
The MLD Resource Centre is independently developed and managed by EiP in terms of content, topics and speakers appointed. Unrestricted grants are sought to support EIP activities and Orchard has provided an unrestricted grant to partially support EIP's work on the misdiagnosis of metabolic disorders.
Copyright © *|CURRENT_YEAR|*, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list






This email was sent to *|EMAIL|*
why did I get this?    unsubscribe from this list    update subscription preferences
*|LIST:ADDRESSLINE|*